Showing items 1–100
Human cytomegalovirus vaccine
Grant US-11541113-B2
United States of America
Zoonotic disease RNA vaccines
Grant US-11497807-B2
United States of America
Human cytomegalovirus RNA vaccines
Grant US-11484590-B2
United States of America
Human cytomegalovirus vaccine
Grant US-11406703-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-11369691-B2
United States of America
CHIKV RNA vaccines
Grant US-11364292-B2
United States of America
HMPV/hPIV3 mRNA vaccine composition
Grant US-11351242-B1
United States of America
Engineering and delivery of therapeutic compositions of freshly isolated cells
Grant US-11331344-B2
United States of America
Zika virus RNA vaccines
Grant US-11278611-B2
United States of America
Chikungunya virus RNA vaccines
Grant US-11235052-B2
United States of America
Zika virus mRNA vaccines
Grant US-11207398-B2
United States of America
Human cytomegalovirus vaccine
Grant US-11197927-B2
United States of America
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-11135312-B2
United States of America
Respiratory virus nucleic acid vaccines
Grant US-11103578-B2
United States of America
Infectious disease vaccines
Grant US-11007260-B2
United States of America
Betacoronavirus mRNA vaccine
Grant US-10933127-B2
United States of America
Modified RNA with decreased immunostimulatory properties
Grant US-10898584-B2
United States of America
Polynucleotides encoding immune modulating polypeptides
Grant US-10815291-B2
United States of America
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST…
Application EP-3715357-A1
European Patent Office
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID…
Application EP-3708185-A2
European Patent Office
Engineered nucleic acids and methods of use thereof
Grant US-10751386-B2
United States of America
Human cytomegalovirus RNA vaccines
Grant US-10716846-B2
United States of America
Nucleic acid vaccines
Grant US-10709779-B2
United States of America
Betacoronavirus mRNA vaccine
Grant US-10702600-B1
United States of America
HPIV3 RNA vaccines
Grant US-10702599-B2
United States of America
CHIKV RNA vaccines
Grant US-10702597-B2
United States of America
Human cytomegalovirus vaccine
Grant US-10695419-B2
United States of America
Chikungunya virus RNA vaccines
Grant US-10675342-B2
United States of America
Engineering and delivery of therapeutic compositions of freshly isolated cells
Grant US-10660917-B2
United States of America
Zika virus MRNA vaccines
Grant US-10653767-B2
United States of America
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST…
Application EP-3626731-A1
European Patent Office
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST…
Application EP-3626730-A1
European Patent Office
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST…
Application EP-3626729-A1
European Patent Office
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST…
Application EP-3620168-A1
European Patent Office
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST…
Application EP-3616706-A1
European Patent Office
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its…
Grant US-10568972-B2
United States of America
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AM…
Application EP-3604327-A1
European Patent Office
hMPV RNA vaccines
Grant US-10543269-B2
United States of America
Zika virus RNA vaccines
Grant US-10517940-B2
United States of America
Modified polynucleotides
Grant US-10501512-B2
United States of America
Zika RNA vaccines
Grant US-10449244-B2
United States of America
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST…
Application EP-3545965-A2
European Patent Office
Human cytomegalovirus RNA vaccines
Grant US-10383937-B2
United States of America
Polynucleotides encoding low density lipoprotein receptor
Grant US-10323076-B2
United States of America
Combination PIV3/hMPV RNA vaccines
Grant US-10272150-B2
United States of America
High potency immunogenic zika virus compositions
Grant US-10273269-B2
United States of America
Chikagunya virus RNA vaccines
Grant US-10238731-B2
United States of America
Zika virus RNA vaccines
Grant US-10124055-B2
United States of America
Modification of RNA, producing an increased transcript stability and translation…
Grant US-10106800-B2
United States of America
Combination PIV3/hMPV RNA vaccines
Grant US-10064934-B2
United States of America
Human cytomegalovirus RNA vaccines
Grant US-10064935-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-10064959-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-10022425-B2
United States of America
Nucleic acid vaccines
Grant US-10022435-B2
United States of America
Delivery and formulation of engineered nucleic acids
Grant US-9950068-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9937233-B2
United States of America
Modified polynucleotides for the production of cosmetic proteins and peptides
Grant US-9878056-B2
United States of America
Nucleic acid vaccines
Grant US-9872900-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-9828416-B2
United States of America
Modified polynucleotides for the production of proteins
Grant US-9827332-B2
United States of America
Modified polynucleotides for the production of biologics and proteins associated with…
Grant US-9814760-B2
United States of America
Modified polynucleotides for the production of proteins associated with human disease
Grant US-9782462-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9701965-B2
United States of America
Modified polynucleotides encoding hepatitis A virus cellular receptor 2
Grant US-9675668-B2
United States of America
Engineering and delivery of therapeutic compositions of freshly isolated cells
Grant US-9669058-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9657295-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9655955-B2
United States of America
Terminally modified RNA
Grant US-9597380-B2
United States of America
Modified polynucleotides for the production of oncology-related proteins and peptides
Grant US-9587003-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Grant US-9572897-B2
United States of America
Delivery and formulation of engineered nucleic acids
Grant US-9533047-B2
United States of America
Modification of RNA, producing an increased transcript stability and translation…
Grant US-9476055-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9464124-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9463228-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9447164-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9439956-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9433670-B2
United States of America
Application of mRNA for use as a therapeutic against tumor diseases
Grant US-9433669-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9428535-B2
United States of America
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9334328-B2
United States of America
Modified polynucleotides encoding apoptosis inducing factor 1
Grant US-9301993-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Grant US-9303079-B2
United States of America
Formulation and delivery of PLGA microspheres
Grant US-9295689-B2
United States of America
Modified polynucleotides for the production of nuclear proteins
Grant US-9283287-B2
United States of America
Formulation and delivery of PLGA microspheres
Grant US-9271996-B2
United States of America
Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1
Grant US-9255129-B2
United States of America
Modified polynucleotides for the production of proteins
Grant US-9254311-B2
United States of America
Modified polynucleotides for the production of proteins associated with blood and…
Grant US-9233141-B2
United States of America
Modified polynucleotides for the production of proteins associated with blood and…
Grant US-9220755-B2
United States of America
In vivo production of proteins
Grant US-9221891-B2
United States of America
Modified polynucleotides encoding aquaporin-5
Grant US-9220792-B2
United States of America
Modified polynucleotides encoding granulysin
Grant US-9216205-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-9192651-B2
United States of America
Split dose administration
Grant US-9186372-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9181319-B2
United States of America
Application of mRNA for use as a therapeutic against tumour diseases
Grant US-9155788-B2
United States of America
Modified polynucleotides encoding septin-4
Grant US-9149506-B2
United States of America
Engineering and delivery of therapeutic compositions of freshly isolated cells
Grant US-9132153-B2
United States of America
Modified polynucleotides encoding citeD4
Grant US-9114113-B2
United States of America
Showing items 1–100